Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ALK |
| Variant | C1237Y |
| Impact List | missense |
| Protein Effect | gain of function - predicted |
| Gene Variant Descriptions | ALK C1237Y lies within the protein kinase domain of the Alk protein (UniProt.org). C1237Y results in increased Alk autophosphorylation and cell proliferation in the context of EML4-ALK compared to expression of EML4-ALK alone in culture (PMID: 38448512), and has also been demonstrated to confer resistance to Alk inhibitors in the context of EML4-ALK (PMID: 38448512), and therefore, is predicted to lead to a gain of Alk protein function. |
| Associated Drug Resistance | Y |
| Category Variants Paths |
ALK mutant ALK act mut ALK C1237Y |
| Transcript | NM_004304.5 |
| gDNA | chr2:g.29214017C>T |
| cDNA | c.3710G>A |
| Protein | p.C1237Y |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004304.5 | chr2:g.29214017C>T | c.3710G>A | p.C1237Y | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|